According to a news release just issued by Queen’s University, Belfast, a group of 150 researchers around the world is coming together to expand enrollment and access to the Australian INTERVAL trial into a global trial to test whether serious exercise should be prescribed as part of the treatment for men with advanced prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: exercise, high-intensity, interval, survival, trial | 4 Comments »
The April 15 issue of The ASCO Post (a widely circulated magazine for oncologists and others) carries a lead article entitled “Longer screening intervals make sense in men with initial PSA levels < 2 ng/ml.” … READ MORE …
Filed under: Diagnosis, Risk | Tagged: interval, risk, screening, testing | 1 Comment »
A re-analysis of data from the Antwerp (Belgium) section of the European Randomized Study of Screening for Prostate Cancer (ERSPC) has offered us some further insight into the frequency of PSA testing necessary to identify less and more aggressive forms of prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: aggressive, interval, PSA, risk, screening, test | 5 Comments »
Two newly published articles suggest that — among a small group of Canadian patients and a large cohort of US veterans — there was a significant time interval from initial suspicion of prostate cancer to definitive treatment (where necessary). But was this time interval appropriate? … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: Diagnosis, interval, outcome, prognosis, risk, suspicion, Treatment | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 